---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-016447"
form_type: "8-K"
ticker: "TKNO"
cik: "0001850902"
company_name: "Alpha Teknova, Inc."
filed_at: "2022-08-10T23:59:59+00:00"
generated_at: "2026-06-24T01:35:07.797334+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Alpha Teknova reports Q2 2022 revenue of $11.7M, up 41% YoY, updates 2022 outlook to $38-42M

## Summary
- Q2 total revenue reached $11.7 million, a 41% increase from $8.3 million in Q2 2021.
- Net loss for Q2 2022 was $6.2 million ($0.22 per diluted share), compared to net loss of $2.3 million ($0.52 per share) in Q2 2021.
- Adjusted EBITDA was negative $4.9 million in Q2 2022, versus negative $1.5 million in Q2 2021.
- Cash position of $64.7 million; company updates 2022 revenue guidance to $38-$42 million, implying ~13% mid-point growth excluding Sample Transport.
- CEO cited lower-than-expected H2 revenue due to early-stage biopharma customers deferring large purchases.

## SEC filing metadata
- accession: 0000950170-22-016447
- form_type: 8-K
- ticker: TKNO
- cik: 0001850902
- company_name: Alpha Teknova, Inc.
- filed_at: 2022-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850902/000095017022016447/0000950170-22-016447-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850902/000095017022016447/tkno-20220810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-016447
- JSON: https://secwatch.observer/filing/0000950170-22-016447.json
- Plain text: https://secwatch.observer/filing/0000950170-22-016447.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.